Literature DB >> 9855365

The correction of alpha7 nicotinic acetylcholine receptor concentration-response relationships in Xenopus oocytes.

R L Papke1, J S Thinschmidt.   

Abstract

The rapid desensitization of alpha7 nicotinic acetylcholine receptors (nAChR) has presented a serious problem for the characterization of this receptor subtype, potentially confounding the interpretation of concentration-response relationships. However, the consistency of cell geometry and solution flow in oocyte recordings permits estimations of instantaneous concentrations to be made in this system. Results interpreted with predicted instantaneous concentrations suggest that estimates of EC50 derived from conventional analysis may overestimate the actual EC50 values by a factor of 10 and underestimate Hill slopes by a factor of 2-3. If the limiting desensitization process of alpha7 receptors is driven by the agonist concentration itself rather than by time-dependent processes, then similar dependencies may exist between the response and instantaneous agonist concentration in other systems.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9855365     DOI: 10.1016/s0304-3940(98)00786-1

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  36 in total

1.  Rapid desensitization of the rat α7 nAChR is facilitated by the presence of a proline residue in the outer β-sheet.

Authors:  Thomas J McCormack; Claudio Melis; José Colón; Elaine A Gay; Arpad Mike; Robert Karoly; Patricia W Lamb; Carla Molteni; Jerrel L Yakel
Journal:  J Physiol       Date:  2010-09-13       Impact factor: 5.182

2.  Fast synaptic transmission in the goldfish CNS mediated by multiple nicotinic receptors.

Authors:  Charlotte L Grove; Theresa M Szabo; J Michael McIntosh; Samantha C Do; Robert F Waldeck; Donald S Faber
Journal:  J Physiol       Date:  2010-11-29       Impact factor: 5.182

3.  Single-channel and structural foundations of neuronal α7 acetylcholine receptor potentiation.

Authors:  Corrie J B daCosta; Chris R Free; Jeremías Corradi; Cecilia Bouzat; Steven M Sine
Journal:  J Neurosci       Date:  2011-09-28       Impact factor: 6.167

4.  Investigation of the molecular mechanism of the α7 nicotinic acetylcholine receptor positive allosteric modulator PNU-120596 provides evidence for two distinct desensitized states.

Authors:  Dustin K Williams; Jingyi Wang; Roger L Papke
Journal:  Mol Pharmacol       Date:  2011-09-01       Impact factor: 4.436

5.  Heteromeric Neuronal Nicotinic Acetylcholine Receptors with Mutant β Subunits Acquire Sensitivity to α7-Selective Positive Allosteric Modulators.

Authors:  Clare Stokes; Sumanta Garai; Abhijit R Kulkarni; Lucas N Cantwell; Colleen M Noviello; Ryan E Hibbs; Nicole A Horenstein; Khalil A Abboud; Ganesh A Thakur; Roger L Papke
Journal:  J Pharmacol Exp Ther       Date:  2019-06-07       Impact factor: 4.030

6.  Cholinergic control of gamma power in the midbrain spatial attention network.

Authors:  Astra S Bryant; C Alex Goddard; John R Huguenard; Eric I Knudsen
Journal:  J Neurosci       Date:  2015-01-14       Impact factor: 6.167

7.  Interactions of atropine with heterologously expressed and native alpha 3 subunit-containing nicotinic acetylcholine receptors.

Authors:  Julie C Parker; Deboshree Sarkar; Michael W Quick; Robin A J Lester
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

Review 8.  Nicotinic agonists, antagonists, and modulators from natural sources.

Authors:  John W Daly
Journal:  Cell Mol Neurobiol       Date:  2005-06       Impact factor: 5.046

Review 9.  High throughput electrophysiology with Xenopus oocytes.

Authors:  Roger L Papke; Cathy Smith-Maxwell
Journal:  Comb Chem High Throughput Screen       Date:  2009-01       Impact factor: 1.339

10.  Functional magnetic resonance imaging of effects of a nicotinic agonist in schizophrenia.

Authors:  Jason R Tregellas; Ann Olincy; Lynn Johnson; Jody Tanabe; Shireen Shatti; Laura F Martin; Debra Singel; Yiping P Du; Ferenc Soti; William R Kem; Robert Freedman
Journal:  Neuropsychopharmacology       Date:  2009-12-02       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.